P. Godoy, Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and nonparenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME, Archives of Toxicology, vol.87, pp.1315-1530, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00939009

M. Waldherr, Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals?, Archives of Toxicology, vol.92, pp.921-934, 2018.

E. L. Lecluyse, Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation, Eur J Pharm Sci, vol.13, pp.343-368, 2001.

C. Aninat, Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells, Drug Metab. Dispos, vol.34, pp.75-83, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00702085

L. Guo, Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes, Drug Metab. Dispos, vol.39, pp.528-538, 2011.

W. M. Westerink and W. G. Schoonen, Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells, Toxicol In Vitro, vol.21, pp.1581-1591, 2007.

S. Antherieu, Stable Expression, Activity, and Inducibility of Cytochromes P450 in Differentiated HepaRG Cells. Drug Metabolism and Disposition, vol.38, pp.516-525, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00741715

A. Guillouzo, The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics, Chem. Biol. Interact, vol.168, pp.66-73, 2007.

K. P. Kanebratt and T. B. Andersson, Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies, Drug Metab. Dispos, vol.36, pp.1444-1452, 2008.

G. Ates, A novel genotoxin-specific qPCR array based on the metabolically competent human HepaRG TM cell line as a rapid and reliable tool for improved in vitro hazard assessment, Archives of Toxicology, vol.92, pp.1593-1608, 2018.

J. K. Buick, Integration of metabolic activation with a predictive toxicogenomics signature to classify genotoxic versus nongenotoxic chemicals in human TK6 cells, Transcriptomic Genotoxicity Signature. Environmental and Molecular Mutagenesis, vol.56, pp.520-534, 2015.

L. Hegarat and L. , Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays, vol.25, pp.555-560, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00533767

L. Hégarat and L. L. , Performance of Comet and Micronucleus Assays in Metabolic Competent HepaRG Cells to Predict In Vivo Genotoxicity, Toxicological Sciences, vol.138, pp.300-309, 2014.

N. Quesnot, Evaluation of genotoxicity using automated detection of ?H2AX in metabolically competent HepaRG cells, Mutagenesis, vol.059, 2015.

J. Dumont, Differential toxicity of heterocyclic aromatic amines and their mixture in metabolically competent HepaRG cells, Toxicology and Applied Pharmacology, vol.245, pp.256-263, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00533754

G. Mazzoleni, D. Di-lorenzo, and N. Steimberg, Modelling tissues in 3D: the next future of pharmaco-toxicology and food research?, Genes Nutr, vol.4, pp.13-22, 2009.

A. Birgersdotter, R. Sandberg, and I. Ernberg, Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems, Semin. Cancer Biol, vol.15, pp.405-412, 2005.

R. Lin, R. Lin, and H. Chang, Recent advances in three-dimensional multicellular spheroid culture for biomedical research, Biotechnol J, vol.3, pp.1172-1184, 2008.

S. Breslin and L. O'driscoll, Three-dimensional cell culture: the missing link in drug discovery, Drug Discov. Today, vol.18, pp.240-249, 2013.

M. Drewitz, Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues, Biotechnol J, vol.6, pp.1488-1496, 2011.

J. M. Kelm, N. E. Timmins, C. J. Brown, M. Fussenegger, and L. K. Nielsen, Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types, Biotechnol. Bioeng, vol.83, pp.173-180, 2003.

U. Shah, A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies, Mutation Research/Genetic Toxicology and Environmental, vol.825, pp.51-58, 2018.

S. C. Ramaiahgari, From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening, Toxicological Sciences, vol.159, pp.124-136, 2017.

P. Gunness, 3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies, Toxicological Sciences, vol.133, pp.67-78, 2013.

S. B. Leite, Three-dimensional HepaRG model as an attractive tool for toxicity testing, Toxicol. Sci, vol.130, pp.106-116, 2012.

P. J. Ferron, Modulation of CYP3A4 activity alters the cytotoxicity of lipophilic phycotoxins in human hepatic HepaRG cells, Toxicology in Vitro, vol.33, pp.136-146, 2016.
URL : https://hal.archives-ouvertes.fr/anses-01340742

Y. Higuchi, Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes: 3D culture accelerates HepaRG maturation, Hepatology Research, vol.46, pp.1045-1057, 2016.

D. Mueller, L. Krämer, E. Hoffmann, S. Klein, and F. Noor, 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies, Toxicology in Vitro, vol.28, pp.104-112, 2014.

J. P. Jackson, L. Li, E. D. Chamberlain, H. Wang, and S. S. Ferguson, Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures, Drug Metabolism and Disposition, vol.44, pp.1463-1479, 2016.

M. Chevereau, H. Glatt, D. Zalko, J. Cravedi, and M. Audebert, Role of human sulfotransferase 1A1 and N-acetyltransferase 2 in the metabolic activation of 16 heterocyclic amines and related heterocyclics to genotoxicants in recombinant V79 cells, Archives of Toxicology, vol.91, pp.3175-3184, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01604252

M. Pezdirc, B. ?egura, and M. Filipi?, Genotoxicity and induction of DNA damage responsive genes by food-borne heterocyclic aromatic amines in human hepatoma HepG2 cells, Food and Chemical Toxicology, vol.59, pp.386-394, 2013.

M. Mi?ík, Cytome micronucleus assays with a metabolically competent human derived liver cell line (Huh6): A promising approach for routine testing of chemicals?, Micronucleus Test with New Cell Line Huh6, vol.60, pp.134-144, 2019.

K. Habas, DNA damage protection by bulk and nano forms of quercetin in lymphocytes of patients with chronic obstructive pulmonary disease exposed to the food mutagen 2-amino-3-methylimidazo [4,5-f]quinolone (IQ), Environmental Research, vol.166, pp.10-15, 2018.

S. Anthérieu, C. Chesné, R. Li, C. Guguen-guillouzo, and A. Guillouzo, Optimization of the HepaRG cell model for drug metabolism and toxicity studies, Toxicol In Vitro, vol.26, pp.1278-1285, 2012.

J. E. Deweese and N. Osheroff, The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing, Nucleic Acids Res, vol.37, pp.738-748, 2009.

C. C. Bell, Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease, Scientific Reports, vol.6, 2016.

C. C. Bell, Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study, Toxicological Sciences, vol.162, pp.655-666, 2018.

P. Godoy, Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis, Hepatology, vol.49, pp.2031-2043, 2009.

T. Hurrell, A. A. Ellero, Z. F. Masso, and A. D. Cromarty, Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro, Toxicology in Vitro, vol.50, pp.86-94, 2018.

C. Luckert, Comparative analysis of 3D culture methods on human HepG2 cells, Archives of Toxicology, vol.91, pp.393-406, 2017.

P. Sykora, Next generation high throughput DNA damage detection platform for genotoxic compound screening, Scientific Reports, vol.8, 2018.